Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan-Reference-Cited by-同舟云学术

Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan

Published:2020-11-05 Issue:2 Volume:26 Page:378-386
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Nakao Tomomi,Kaneko Rena^ORCID,Tanaka Hirokazu,Kobayashi Shunsuke,Omori Risa,Yano Yuichiro,Kamada Kentaro,Ikehara Takashi,Sato Yuzuru,Igarashi Yoshinori

Funder

Japan Organization of Occupational Health and Safety

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-020-01820-9.pdf

Reference46 articles.

1. Balakrishnan M, George R, Sharma A et al (2017) Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep 19(8):36. https://doi.org/10.1007/s11894-017-0575-8

2. International Agency for Research of Cancer (IARC). Cancer Incidence in Five Continents, Vol. XI (electronic version)

3. Moradi G, Karimi K, Esmailnasab N et al (2016) Survival of patients with stomach cancer and its determinants in Kurdistan. Asian Pac J Cancer Prev: APJCP 17(7):3243–3248

4. Leung WK, Wu MS, Kakugawa Y et al (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9(3):279–287. https://doi.org/10.1016/s1470-2045(08)70072-x

5. Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5(1):1–5. https://doi.org/10.1007/s101200200000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The survival outcome in proximal and distal gastric neuroendocrine carcinoma - A SEER-based competing risk nomogram;2024-08-09

2. An Overview of Cancer Biology, Pathophysiological Development and It’s Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy;Cancer Investigation;2024-06-14

3. Prognostic Impact of Perioperative CA125 Status in Gastric Cancer Based on New Cutoff Values;Cureus;2024-06-03

4. Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis;Cancer Medicine;2024-06

5. Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis;International Journal of Clinical Oncology;2023-07-11